{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:26:08Z","timestamp":1792070768608,"version":"4.4.0"},"reference-count":123,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a prevalent disorder in the modern world, affecting around 6%\u201320% of females of childbearing age. Hormonal and metabolic symptoms vary over time but often arise throughout puberty. Treatment includes lifestyle interventions as a first line of treatment. In certain cases, specific medications may be considered. However, there is a growing interest in using Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in PCOS due to their efficacy in weight loss, insulin resistance, and heart health. Aside from the metabolic role of GLP-1RAs, which aids in the relief of PCOS symptoms, there is also the possibility of direct involvement in reproductive health in PCOS, including its role in the hypothalamic-gonadal axis, menstrual irregularity, ovulation, ovarian morphology, anti-inflammatory properties, and fertility. This review discusses the latest data on GLP-1RAs\u2019 metabolic and reproductive health benefits in PCOS. Moreover, this article covers pharmaceutical interactions and synergistic effects of drugs, including metformin and other medications, with GLP-1RAs. It also conveys an overview of recent clinical trials utilizing GLP-1RAs to treat PCOS.<\/jats:p>","DOI":"10.1177\/20420188251383064","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:26:06Z","timestamp":1759897566000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9475-3619","authenticated-orcid":false,"given":"Bassel H.","family":"Hoteit","sequence":"first","affiliation":[{"name":"Faculty of Medical Sciences, Lebanese University, Hadath, Basta Et Tahta 11011, Beirut, Lebanon"},{"name":"MEDICA Research Investigation, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-392X","authenticated-orcid":false,"given":"Jana","family":"Kotaich","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon"},{"name":"MEDICA Research Investigation, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4399-3030","authenticated-orcid":false,"given":"Hadi","family":"Ftouni","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon"},{"name":"MEDICA Research Investigation, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8600-7500","authenticated-orcid":false,"given":"Fatima","family":"Hazime","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Beirut Arab University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-5060","authenticated-orcid":false,"given":"Abdallah","family":"Safawi","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon"},{"name":"MEDICA Research Investigation, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9106-395X","authenticated-orcid":false,"given":"Rim","family":"Masri","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon"},{"name":"MEDICA Research Investigation, Hadath, Lebanon"},{"name":"Department of Endocrinology, Rafic Hariri University Hospital, Hammana 5266, Mount Lebanon, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4471-5642","authenticated-orcid":false,"given":"Mia","family":"Marwani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Rafic Hariri University Hospital, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02625-7"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.04.008"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41"},{"key":"e_1_3_5_8_2","first-page":"22","article-title":"Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies","volume":"3","author":"Kanbour SA","year":"2022","unstructured":"Kanbour SA, Dobs AS. Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies. Androg Clin Res Ther 2022; 3: 22\u201330.","journal-title":"Androg Clin Res Ther"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2018.08.005"},{"key":"e_1_3_5_10_2","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"15","author":"Barber TM","year":"2015","unstructured":"Barber TM, Dimitriadis GK, Andreou A, et al. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2015; 15(Suppl. 6): s72\u2013s76.","journal-title":"Clin Med (Lond)"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.61622\/rbgo\/2024FPS11"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0336-x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000334"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3285"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(11)09"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185915"},{"key":"e_1_3_5_18_2","unstructured":"Corcoran C Jacobs TF. Metformin. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518983\/ (2025 accessed 22 May 2025)."},{"key":"e_1_3_5_19_2","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley LC","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2017; 11: CD003053.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_20_2","unstructured":"Eggleton JS Jialal I. Thiazolidinediones. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551656\/ (2025 accessed 22 May 2025)."},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa285"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12465"},{"issue":"9","key":"e_1_3_5_23_2","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review","volume":"16","author":"Hamed K","year":"2024","unstructured":"Hamed K, Alosaimi MN, Ali BA, et al. Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review. Cureus 2024; 16(9): e68390.","journal-title":"Cureus"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.008"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1414"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0498"},{"key":"e_1_3_5_27_2","article-title":"A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS","volume":"20","author":"Bader S","year":"2024","unstructured":"Bader S, Bhatti R, Mussa B, et al. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS. Womens Health (Lond) 2024; 20: 17455057241234530.","journal-title":"Womens Health (Lond)"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081989"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084334"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex308"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569"},{"key":"e_1_3_5_32_2","article-title":"Insulin resistance in polycystic ovarian syndrome","volume":"14","author":"Purwar A","year":"2022","unstructured":"Purwar A, Nagpure S. Insulin resistance in polycystic ovarian syndrome. Cureus 2022; 14: e30351.","journal-title":"Cureus"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1292125"},{"key":"e_1_3_5_34_2","article-title":"Clinical effects of glucagon-like peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review","volume":"16","author":"Frangie Machado M","year":"2024","unstructured":"Frangie Machado M, Shunk T, Hansen G, et al. Clinical effects of glucagon-like peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review. Cureus 2024; 16: e66691.","journal-title":"Cureus"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.04.027"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6820377"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/758656"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S484531"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26498"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2592-3"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf9382"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12369"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.12.020"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz019"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00973.x"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/151695"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000442721"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021703"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223845"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13454"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13053"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.11.007"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-07-0586"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.7221"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102849"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.103021"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-015-0518-1"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.12.027"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3976-7"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3855"},{"key":"e_1_3_5_63_2","first-page":"72","article-title":"Hemodynamic effect of a single dose of glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide in patients with diabetic kidney disease","author":"Wajdlich M","year":"2021","unstructured":"Wajdlich M, Nowicki M. Hemodynamic effect of a single dose of glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide in patients with diabetic kidney disease. J Physiol Pharmacol 2021; 72.","journal-title":"J Physiol Pharmacol"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab345"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0327"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3497"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1484321"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0198-16.2016"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0115"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1978"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00214"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01621-6"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13093"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113304"},{"key":"e_1_3_5_75_2","unstructured":"Allen MJ Sharma S. Physiology adrenocorticotropic hormone (ACTH). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500031\/ (2025 accessed 5 August 2025)."},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(98)00096-3"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-15-06163.2003"},{"key":"e_1_3_5_78_2","article-title":"GLP-1R\/NPY2R regulate gene expression, ovarian and adrenal morphology in HFD mice","volume":"264","author":"Khan D","year":"2025","unstructured":"Khan D, Sridhar A, Moffett CR. GLP-1R\/NPY2R regulate gene expression, ovarian and adrenal morphology in HFD mice. J Endocrinol 2025; 264: e240189.","journal-title":"J Endocrinol"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109609"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01420"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01500-5"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.03.023"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170624"},{"key":"e_1_3_5_84_2","first-page":"8276","article-title":"Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide","volume":"8","author":"Tao X","year":"2015","unstructured":"Tao X, Zhang X, Ge S-Q, et al. Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide. Int J Clin Exp Pathol 2015; 8: 8276\u20138283.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i1.5"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.975686"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-3-15"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S344542"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0175"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00834"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.03.032"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2013.06.016"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31823f7135"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043745"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.2337\/ds19-0062"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1364110"},{"key":"e_1_3_5_97_2","unstructured":"Leek JC Arif H. Pregnancy medications. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507858\/ (2024 accessed 3 November 2024)."},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083550"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.08.024"},{"key":"e_1_3_5_100_2","unstructured":"European Platform on Rare Disease Registration. Prevalence charts and tables https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence_en (2024 accessed 4 December 2024)."},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.6663"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2023.10.037"},{"key":"e_1_3_5_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4336-x"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2368"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026295"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.04.017"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2022.100016"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010145"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab408"},{"key":"e_1_3_5_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13704"},{"key":"e_1_3_5_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07637-5"},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.2015.1079610"},{"key":"e_1_3_5_113_2","volume-title":"Cochrane database of systematic reviews","author":"Gallo MF","unstructured":"Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. In: The Cochrane Collaboration (ed.) Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd, p. CD003987.pub2."},{"issue":"8","key":"e_1_3_5_114_2","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"Lopez LM","year":"2016","unstructured":"Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; 2016(8): CD008815.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.05.002"},{"key":"e_1_3_5_116_2","doi-asserted-by":"publisher","DOI":"10.7570\/jomes.2017.26.2.102"},{"key":"e_1_3_5_117_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa337"},{"key":"e_1_3_5_118_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01779-z"},{"key":"e_1_3_5_119_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03487-4"},{"key":"e_1_3_5_120_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001712"},{"key":"e_1_3_5_121_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0161-3"},{"key":"e_1_3_5_122_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126119"},{"key":"e_1_3_5_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52898-y"},{"key":"e_1_3_5_124_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00450"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251383064","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420188251383064","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251383064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:37:04Z","timestamp":1777592224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420188251383064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":123,"alternative-id":["10.1177\/20420188251383064"],"URL":"https:\/\/doi.org\/10.1177\/20420188251383064","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"20420188251383064"}}